Pharma & Biotech

The curtain is closing on ViewRay as the company enters the final stage of its corporate existence. With the bankruptcy...

The biotechnology sector has a new standout performer, and its name is Liquidia. The company is currently authoring one of...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating its most significant corporate crisis in recent memory. A dramatic sequence...

Vaxxinity's stock is experiencing a period of intense pressure, having collapsed to record lows while displaying extraordinary price swings. The...

The chapter on Walgreens Boots Alliance as a publicly traded entity has officially closed. In August 2025, the company was...

The story of Viracta Therapeutics serves as a stark reminder of the high-risk nature of biotechnology investing, culminating in what...

Eli Lilly and Company is making substantial strategic moves to secure its long-term market position through significant European investment and...

The stock of clinical-stage biopharmaceutical company Inhibrx Biosciences has experienced a dramatic ascent, appreciating by a remarkable 120 percent over...

A dramatic boardroom overhaul at pharmaceutical giant Novo Nordisk has cemented the controlling foundation's authority, triggering apprehension among minority shareholders...

Eli Lilly & Co. has demonstrated remarkable market performance this week, propelled by growing confidence in the pharmaceutical giant's weight-loss...